FDA Clears Withings' Multi-Function Medical Device BeamO
In a significant development for telehealth services, the US Food and Drug Administration (FDA) has granted clearance to Withings' innovative medical device, BeamO. This portable, multi-functional device can perform an electrocardiogram, a stethoscope reading, and body temperature measurement – all in under one minute.
The FDA approval marks a major milestone for BeamO, which was unveiled at CES 2024 and is now available for purchase. The device will retail for $250 and boasts a range of features that are set to revolutionize the way patients access medical care remotely. A companion app allows users to send their test results directly to healthcare professionals, who can then review them online.
Withings' goal with BeamO is to provide an accessible tool for early detection and monitoring of cardiovascular health issues. The company's Cardio Check-Up service, which integrates with BeamO, enables patients to receive a remote cardiac assessment from certified cardiologists within 24 hours.
This latest innovation from Withings, a company known for its eclectic range of smart home devices – including a futuristic bathroom scale and toilet-mounted computer – further highlights the company's commitment to expanding access to healthcare services.
In a significant development for telehealth services, the US Food and Drug Administration (FDA) has granted clearance to Withings' innovative medical device, BeamO. This portable, multi-functional device can perform an electrocardiogram, a stethoscope reading, and body temperature measurement – all in under one minute.
The FDA approval marks a major milestone for BeamO, which was unveiled at CES 2024 and is now available for purchase. The device will retail for $250 and boasts a range of features that are set to revolutionize the way patients access medical care remotely. A companion app allows users to send their test results directly to healthcare professionals, who can then review them online.
Withings' goal with BeamO is to provide an accessible tool for early detection and monitoring of cardiovascular health issues. The company's Cardio Check-Up service, which integrates with BeamO, enables patients to receive a remote cardiac assessment from certified cardiologists within 24 hours.
This latest innovation from Withings, a company known for its eclectic range of smart home devices – including a futuristic bathroom scale and toilet-mounted computer – further highlights the company's commitment to expanding access to healthcare services.